Capital Bank & Trust CO Biogen Inc. Transaction History

Capital Bank & Trust CO

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $29,745 - $39,393	-115 Closed	0 $0
Q4 2019 Feb 18, 2020	SELL	$220.06 - $304.07 $2,200 - $3,040	-10 Reduced 8.0%	115 $34,000
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $2,174 - $2,438	10 Added 8.7%	125 $29,000
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $219 - $241	-1 Reduced 0.86%	115 $27,000
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $13,219 - $20,676	-61 Reduced 34.46%	116 $27,000
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $1,671 - $2,116	-6 Reduced 3.28%	177 $53,000
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $5,407 - $6,445	21 Added 12.96%	183 $53,000
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $1,845 - $2,067	6 Added 3.85%	162 $52,000
Q3 2017 Nov 14, 2017	SELL	$281.15 - $329.69 $4,217 - $4,945	-15 Reduced 8.77%	156 $49,000
Q2 2017 Aug 14, 2017	BUY	N/A	171	171 $46,000

1,038

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Capital Bank & Trust CO, based on Form 13F filings with the SEC.

Stay updated on Capital Bank & Trust CO with notifications on news.